Board meeting set for Q2 and half-year results approval

Revenue growth above 20%Net loss reportedNegative operating cash flowDebt to equity above the thresholdResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹22.15

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%+0.1% vs market

Specialty Chemicals peers, median of 100sector+1.9%-0.3% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6+1.4+0.1+1.9-0.3

Next day

+1.6+1.7-0.1+0.9+0.7

+1.6+3.9-2.3+2.4-0.8

-0.7+5.1-5.8+2.9-3.6

+1.6pendingpending+2.6-1.1

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on 5 November 2026 to approve the company's unaudited financial results for the quarter and six months ended 30 September 2026. Trading in company shares is closed from 1 October until 48 hours after the results are published.

Likely market impact

No financial figures have been disclosed yet. Share trading remains closed until 48 hours after results, when investor reaction may affect the stock.

By the numbersStandalone · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹12.03 Cr	₹5.53 Cr	+117.3%
Operating profit	−₹0.92 Cr	−₹0.63 Cr	loss widened
Profit after tax	−₹0.90 Cr	−₹0.60 Cr	loss widened
EBITDA margin	-4.3%	-3.9%	−0.4 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.